Medical Devices Investors & VC Firms in North America
1074 firms in this list, with a median first check of $500K. 236 of them lead rounds. Generated from verified public data and updated continuously.
Boutique Venture Partners
Palo AltoSeed–Series A
18 people
Forepont Capital Partners
New YorkPre-Seed–Series A
26 people
SteelSky Ventures
AtlantaSeed$100K – $5M
11 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
Allos Ventures
CincinnatiSeed–Series A$1M – $6M
7 people
WRF Capital
SeattlePre-Seed–Series A$100K – $2M
22 people
OVNI Capital
San FranciscoPre-Seed–Series A$250K – $2M
11 people
Slater Technology Fund
ProvidencePre-Seed–Series A
17 people
OSF Ventures
PeoriaSeed–Series A
19 people
Pivotal Life Sciences
San FranciscoPre-Seed–Late Stage
15 people
THL FUND
BostonGrowth
24 people
Geekdom
San AntonioPre-Seed–Seed$50K – $500K
5 people
Owl Rock Capital
New YorkGrowth–Late Stage$20M – $250M
20 people
Cowtown Angels
Fort WorthPre-Seed–Series A
12 people
MEDA Angels
ArlingtonSeed–Series A$130K – $350K
18 people
Dellin Investments
PhiladelphiaPre-Seed–Growth
7 people
Ajax Health
Menlo ParkSeed–Late Stage
27 people
MedTech Venture Partners
Menlo ParkSeed–Series A
29 people
Civilization Ventures Management, Llc
TiburonPre-Seed–Growth$1M – $10M
3 people
Standard Capital
San FranciscoSeries A
9 people
LOUD Capital
ColumbusSeed–Growth
26 people
Agility Capital
Santa BarbaraGrowth$250K – $1.5M
4 people
LYFE Capital
Menlo ParkSeed–Late Stage
22 people
Sixty Degree Capital
North YorkPre-Seed–Growth
17 people
Related lists
Investors & VC Firms in North America (13518)Investors & VC Firms in United States (12555)Investors & VC Firms in Europe (5846)Investors & VC Firms in Global (4720)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4215)Healthtech Investors & VC Firms (4185)Enterprise Software Investors & VC Firms (4097)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.




































































































